# Norfloxacin In The Primary Prophylaxis Of Spontaneous Bacterial Peritonitis

> **NCT00359853** · PHASE4 · COMPLETED · sponsor: **Hospital Clinic of Barcelona** · enrollment: 70 (—)

## Conditions studied

- Spontaneous Bacterial Peritonitis
- Hepatorenal Syndrome
- Cirrhosis

## Interventions

- **DRUG:** Oral norfloxacin

## Key facts

- **NCT ID:** NCT00359853
- **Lead sponsor:** Hospital Clinic of Barcelona
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-09
- **Primary completion:** —
- **Final completion:** 2005-03
- **Target enrollment:** 70 (—)
- **Last updated:** 2006-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00359853

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00359853, "Norfloxacin In The Primary Prophylaxis Of Spontaneous Bacterial Peritonitis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00359853. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*